Weibond Technology, established in 2009, is a robotic technology innovator in IV compounding automation. Our vision is to revolutionize the way pharmacists and nurses do sterile IV compounding through reliable, innovative robotic technology while improving the quality of life for patients and caregivers in the global healthcare community.
Weibond Technology is the first world-class medical equipment manufacturing and services company from China to exhibit at American Society of Health-System Pharmacists Midyear Clinical Exhibition December 3-5, 2018. The company is making its global debut of the Weinas (Weibond Intravenous Assistant System) product line. Two automated robotic system models are exhibited:
- WEINAS PD-160 Series – Compatible with both Vials and Ampoule drug containers
- WEINAS VD-160 Series – Vials Compatible
Operational demonstrations will be conducted on site to professional pharmacists and industry professionals from all over the world.
These systems represent 10 years of research and development, along with over 2 years of successful clinical hospital application at several institutions in China. Developed entirely in China, and granted over 150 patents, the company’s robotic IV drug compounding systems offer patient and occupational safety, accountable accuracy recording, compounding speed, and cost efficiency. WEINAS Compounding Robots are the solution for Hospital Pharmacies and Medical Compounding Operations.
Clinical Study Outcomes
- 1-5 minutes per IV bag per patient
- 54.72 ~ 57.84 sec per vial or ampoule
- Drug compatibility: 95.77%
- ZERO occupational injury due to needles / glass
- 0% Failure on Vials
- 0.026% Failure on Ampoules (mostly glass quality)
Read More: Entersekt Accelerates Growth In Europe